Volume 134, Issue 7, Pages (June 2008)

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States  Michael D. Kappelman, Sheryl L. Rifas–Shiman,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Patients with ulcerative colitis responding to steroid treatment up-regulate glucocorticoid receptor levels in colorectal mucosa  L. Flood, E. Innala,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis  Konstantinos.
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Volume 129, Issue 1, Pages (July 2005)
Hongzhi Zou, Jonathan J. Harrington, Aravind Sugumar, Kristie K
Reply Gastroenterology
Volume 135, Issue 5, Pages e24 (November 2008)
Abatacept for Crohn's Disease and Ulcerative Colitis
Diagnosis of celiac sprue
Covering the Cover Gastroenterology
Volume 136, Issue 2, Pages (February 2009)
Covering the Cover Gastroenterology
Volume 152, Issue 1, Pages e8 (January 2017)
Volume 144, Issue 5, Pages (May 2013)
James E. Everhart, Constance E. Ruhl  Gastroenterology 
Volume 147, Issue 4, Pages e7 (October 2014)
Kirsten Tillisch, Jennifer S. Labus  Gastroenterology 
Volume 132, Issue 1, Pages (January 2007)
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010  Tine Jess, Morten Frisch, Jacob Simonsen 
Volume 153, Issue 2, Pages e3 (August 2017)
Mucosal Healing in Patients With Celiac Disease and Outcomes of Pregnancy: A Nationwide Population-Based Study  Benjamin Lebwohl, Olof Stephansson, Peter.
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
Volume 154, Issue 5, Pages (April 2018)
Covering the Cover Gastroenterology
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 139, Issue 6, Pages e1 (December 2010)
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Volume 137, Issue 2, Pages (August 2009)
Volume 133, Issue 1, Pages (July 2007)
Reply Gastroenterology
Volume 152, Issue 1, Pages (January 2017)
Volume 153, Issue 6, Pages e8 (December 2017)
Serotonin Synthesis and Uptake in Symptomatic Patients With Crohn’s Disease in Remission  Itta M. Minderhoud, Bas Oldenburg, Marguerite E.I. Schipper,
This Month in Gastroenterology
Hongzhi Zou, Jonathan J. Harrington, Aravind Sugumar, Kristie K
Volume 147, Issue 6, Pages e5 (December 2014)
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Efficient Early Drug Development for Ulcerative Colitis
Volume 153, Issue 4, Pages (October 2017)
Kathrine Frey Frøslie, Jørgen Jahnsen, Bjørn A. Moum, Morten H. Vatn 
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis  Konstantinos.
Volume 136, Issue 5, Pages (May 2009)
Bowel Urgency in Patients With Irritable Bowel Syndrome
Rebecca M. Lovell, Alexander C. Ford 
Volume 150, Issue 5, Pages (May 2016)
Volume 128, Issue 7, Pages (June 2005)
Volume 149, Issue 6, Pages (November 2015)
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Rectal Mucosal Nitric Oxide in Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome  Claudia I. Reinders, Max Herulf, Tryggve Ljung,
Volume 150, Issue 7, Pages (June 2016)
Volume 140, Issue 6, Pages e2 (May 2011)
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
Volume 131, Issue 2, Pages (August 2006)
Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders  Evan S. Dellon, MD,
Volume 136, Issue 7, Pages (June 2009)
Volume 135, Issue 6, Pages (December 2008)
Quantitative Meta-analysis Identifies Brain Regions Activated During Rectal Distension in Irritable Bowel Syndrome  Kirsten Tillisch, Emeran A. Mayer,
Serum markers detect the presence of liver fibrosis: A cohort study
Volume 139, Issue 1, Pages (July 2010)
The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States  Michael D. Kappelman, Sheryl L. Rifas–Shiman,
Issue Highlights Clinical Gastroenterology and Hepatology
Bowel Urgency in Patients With Irritable Bowel Syndrome
Volume 156, Issue 4, Pages (March 2019)
Presentation transcript:

Volume 134, Issue 7, Pages 1869-1881 (June 2008) Multigene Analysis Can Discriminate Between Ulcerative Colitis, Crohn's Disease, and Irritable Bowel Syndrome  Petra von Stein, Robert Lofberg, Nikolai V. Kuznetsov, Alexander W. Gielen, Jan–Olov Persson, Rolf Sundberg, Karin Hellstrom, Anders Eriksson, Ragnar Befrits, Ake Ost, Oliver D. von Stein  Gastroenterology  Volume 134, Issue 7, Pages 1869-1881 (June 2008) DOI: 10.1053/j.gastro.2008.02.083 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Screening and identification of 7 IBD-specific genes. (A) From 8 UC and 8 CD patients, mucosal biopsy specimens were collected from inflamed and noninflamed regions of the colon. RNA material derived from the UC patients was used to enrich dysregulated genes using the subtractive suppression hybridization (ssh) procedure. After the screening process, genes were selected for validation in 8 UC and CD patients resulting in the selection of 7 genes. (B) Seven potential IBD discriminating genes were found to be oppositely regulated in inflamed and noninflamed colon biopsy specimens. Plotted are the mean ΔCt value of fold induction/repression of SLC6A14, SLC26A2, GRO-α, MMP-7, SPAP, RegIV, and Vanin-1 in UC (■) and CD () patients. Gastroenterology 2008 134, 1869-1881DOI: (10.1053/j.gastro.2008.02.083) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Overview of the included patients in the 3 performed studies. Gastroenterology 2008 134, 1869-1881DOI: (10.1053/j.gastro.2008.02.083) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Each disease has a typical expression signature. Depicted are ΔCt values for each of the marker genes plotted horizontally to obtain a specific profile pattern. (A) Expression signatures of 3 UC, 3 CD, and 3 IBS patients. (B) Expression signatures derived by plotting the mean ΔCt values (y-axis) against the individual markers (x-axis) obtained from the pilot and prospective study. The qPCR derived ΔCt values were grouped according to the clinical diagnosis (dashed line) or according to the multigene algorithm outcome (solid line) and the mean values of each group for all 7 markers were plotted. (C) Expression signatures of inflamed tissue of other gastrointestinal diseases. Shown are 4 cases of collagenous colitis, 2 cases of diverticulitis, and 1 case each of infectious colitis and solitary rectal ulcer (red line/full circle). As references, the mean of 5 healthy volunteers (green line/open square) were used as well as the mean of all UC cases of prospective study (dashed line), the mean of all CD cases of prospective study (dotted line) and a noninflamed control of solitary rectal ulcer (blue line/open square). [1]SLC6A14, [2]SLC26A2, [3]GRO-α, [4]MMP-7, [5]SPAP, [6]RegIV, [7]Vanin-1. Gastroenterology 2008 134, 1869-1881DOI: (10.1053/j.gastro.2008.02.083) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Each disease has a typical expression signature. Depicted are ΔCt values for each of the marker genes plotted horizontally to obtain a specific profile pattern. (A) Expression signatures of 3 UC, 3 CD, and 3 IBS patients. (B) Expression signatures derived by plotting the mean ΔCt values (y-axis) against the individual markers (x-axis) obtained from the pilot and prospective study. The qPCR derived ΔCt values were grouped according to the clinical diagnosis (dashed line) or according to the multigene algorithm outcome (solid line) and the mean values of each group for all 7 markers were plotted. (C) Expression signatures of inflamed tissue of other gastrointestinal diseases. Shown are 4 cases of collagenous colitis, 2 cases of diverticulitis, and 1 case each of infectious colitis and solitary rectal ulcer (red line/full circle). As references, the mean of 5 healthy volunteers (green line/open square) were used as well as the mean of all UC cases of prospective study (dashed line), the mean of all CD cases of prospective study (dotted line) and a noninflamed control of solitary rectal ulcer (blue line/open square). [1]SLC6A14, [2]SLC26A2, [3]GRO-α, [4]MMP-7, [5]SPAP, [6]RegIV, [7]Vanin-1. Gastroenterology 2008 134, 1869-1881DOI: (10.1053/j.gastro.2008.02.083) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 ROC plots of the prospective study. The calculated probabilities of having UC or CD or non-IBD derived from the multigene analysis of the 7 marker genes were compared with the overall clinical assessment as gold standard. Each ROC plot had a P value of less than .0001. Gastroenterology 2008 134, 1869-1881DOI: (10.1053/j.gastro.2008.02.083) Copyright © 2008 AGA Institute Terms and Conditions

Figure 5 Individual box plot analysis of all 7 markers in comparison to the control lactoferrin. Patient cDNA was analyzed by qPCR and the resulting ΔCt values plotted per disease (CD, IBS/non-IBD, and UC). Shown are the median, the upper and lower quartiles, and the whole distribution of the values of all included patients per group (A) Pilot study CD (n=13), IBS (n=8), UC (n=22). (B) Prospective study CD (n=22), non-IBD (n=88), UC (n=55). Gastroenterology 2008 134, 1869-1881DOI: (10.1053/j.gastro.2008.02.083) Copyright © 2008 AGA Institute Terms and Conditions